RecruitingPhase 4NCT04248205

Ketamine for Post-operative Analgesia in Hemorrhoidectomy

Intra-operative Use of Ketamine for Post-Operative Analgesia in Patients Undergoing Hemorrhoidectomy: A Prospective, Randomized Controlled Trial.


Sponsor

University of Oklahoma

Enrollment

100 participants

Start Date

Jun 15, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

This is a prospective, randomized study of ketamine versus no ketamine in approximately 100 patients undergoing hemorrhoidectomy for Grade III or IV hemorrhoids. The participants will be blinded to which treatment arm they are assigned, because participants will be under anesthesia when the ketamine is administered. The investigators will know whether the participant receives ketamine or not.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether the drug ketamine can help reduce pain after hemorrhoid removal surgery (hemorrhoidectomy), so patients need less opioid pain medication after their procedure. **You may be eligible if:** - You are an adult between 18 and 100 years old - You are scheduled to have a hemorrhoidectomy for grade III or IV hemorrhoids (moderate to severe) **You may NOT be eligible if:** - You are unable to safely receive general anesthesia - You have a history of schizophrenia, psychosis, or other conditions that cause hallucinations - You use chronic narcotic (opioid) medications — defined as having a pain management contract and regular opioid use Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGKetamine

Standard general anesthesia PLUS ketamine will be given for post-operative analgesia


Locations(1)

University of Oklahoma Health Sciences Center

Oklahoma City, Oklahoma, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04248205


Related Trials